View in EDS

Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial.

Saved in:
Bibliographic Details
Title: Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial.
Authors: Leleu X; Hematology, CIC 1082, U1313, CHU, University, Poitiers, France. xavier.leleu@chu-poitiers.fr., Hulin C; CHU, Bordeaux, France., Lambert J; SBIM, Saint-Louis Hospital, Paris, France., Bobin A; Hematology, CIC 1082, U1313, CHU, University, Poitiers, France., Perrot A; University Hospital, iUCT Oncopole, Toulouse, France., Karlin L; Hôpital Lyon Sud, Pierre-Benite, France., Roussel M; Hematology, CHU, Limoges, France., Montes L; Hematology, CHU, Amiens, France., Cherel B; CH Bretagne Atlantique, Vannes, France., Chalopin T; Hematology, CHU, Tours, France., Slama B; Hospital center, Avignon, France., Chretien ML; Hematology, University Hospital, Inserm U1231, University of Burgundy Franche-Comté, Dijon, France., Laribi K; Hematology, CH, Le Mans, France., Dingremont C; Internal Medicine, Tarbes-Lourdes Hospital, Tarbes, France., Roul C; CH La Rochelle, La Rochelle, France., Mariette C; Hematology, CHU, Grenoble, France., Rigaudeau S; Hématologie - Le Chesnay, CH Versaille, Paris, France., Calmettes C; CH, Périgueux, France., Dib M; University Hospital, Angers, France., Tiab M; Hematology, CH Departemental de La Roche-sur-Yon, La Roche-sur-Yon, France., Vincent L; CHU, Montpellier, France., Delaunay J; Hôpital privé du confluent 2, Nantes, France., Santagostino A; Hematology, CH, Troyes, France., Macro M; Hematology, IHBN - CHU, Caen, France., Bourgeois E; GHICL, Lille, France., Orsini-Piocelle F; Hématologie, CH, Annecy Genevois, France., Gay J; Hematology, CH de la côte basque, Bayonne, France., Bareau B; Hematology, Les Hôpitaux Privés Rennais Cesson Sévigné - Vivalto Santé, Cesson Sévigné, France., Bigot N; SBIM, Saint-Louis Hospital, Paris, France., Vergez F; Unit for Genomics in Myeloma, iUCT Oncopole, Toulouse, France., Lebreton P; Hematology, CH, Le Havre, France., Tabrizi R; Hematology, CHI de Mont De Marsan, Mont-de-Marsan, France., Waultier-Rascalou A; Hematology, CHU, Nîmes, France., Frenzel L; Hematology, Necker Hospital, Paris, France., Le Calloch R; Hematology, CH de Cornouaille, Quimper Concarneau, Concarneau, France., Chalayer E; Hematology, CHU, Saint-Etienne, France., Braun T; Hematology, Avicenne hospital APHP, Bobigny, France., Lachenal F; CH Pierre Oudot, Bourgoin-Jallieu, France., Corm S; Medipole de Savoie, Challes les Eaux, France., Kennel C; CH William Morey, Chalon sur Saône, France., Belkhir R; Rheumatology, Hopital Bicetre, AP-HP, Universite Paris Saclay, Paris, France., Bladé JS; Onco-Hematology Department, HIA Sainte Anne, Toulon, France., Joly B; CH Sud Francilien, Corbeil Essonnes, France., Richez-Olivier V; CHU de Nice, Nice, France., Gardeney H; Hematology, CIC 1082, U1313, CHU, University, Poitiers, France., Demarquette H; Hematology, CH, Dunkerque, France., Robu-Cretu D; Hematology, CH, Lens, France., Garderet L; Hopital Pitié Salpetriere, hématologie APHP, Paris, France., Newinger-Porte M; Hôpital Emile Muller, Mulhouse, France., Kasmi A; DRC, CHU, Poitiers, France., Royer B; Hôpital Saint-Louis, Paris, France., Decaux O; Hematology, UMR U1236, University Hospital, Rennes, France., Arnulf B; Hôpital Saint-Louis, Paris, France., Belhadj K; C.H.U. Henri Mondor, Créteil, France., Touzeau C; Hématologie, CHU Hotel Dieu Université, Nantes, France., Mohty M; Hematology, Sorbonne University, Saint-Antoine Hôpital (AP-HP), UMRs 938, Paris, France., Manier S; Hematology, University Hospital Inserm U-S1277 and CNRS UMR9020, Lille, France., Moreau P; Hématologie, CHU Hotel Dieu Université, Nantes, France., Avet-Loiseau H; Unit for Genomics in Myeloma, iUCT Oncopole, Toulouse, France., Corre J; Unit for Genomics in Myeloma, iUCT Oncopole, Toulouse, France., Facon T; Hematology, University Hospital Inserm U-S1277 and CNRS UMR9020, Lille, France.
Source: Nature medicine [Nat Med] 2024 Aug; Vol. 30 (8), pp. 2235-2241. Date of Electronic Publication: 2024 Jun 03.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38830994
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Leleu+X%22">Leleu X</searchLink>; Hematology, CIC 1082, U1313, CHU, University, Poitiers, France. xavier.leleu@chu-poitiers.fr.<br /><searchLink fieldCode="AU" term="%22Hulin+C%22">Hulin C</searchLink>; CHU, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Lambert+J%22">Lambert J</searchLink>; SBIM, Saint-Louis Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bobin+A%22">Bobin A</searchLink>; Hematology, CIC 1082, U1313, CHU, University, Poitiers, France.<br /><searchLink fieldCode="AU" term="%22Perrot+A%22">Perrot A</searchLink>; University Hospital, iUCT Oncopole, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Karlin+L%22">Karlin L</searchLink>; Hôpital Lyon Sud, Pierre-Benite, France.<br /><searchLink fieldCode="AU" term="%22Roussel+M%22">Roussel M</searchLink>; Hematology, CHU, Limoges, France.<br /><searchLink fieldCode="AU" term="%22Montes+L%22">Montes L</searchLink>; Hematology, CHU, Amiens, France.<br /><searchLink fieldCode="AU" term="%22Cherel+B%22">Cherel B</searchLink>; CH Bretagne Atlantique, Vannes, France.<br /><searchLink fieldCode="AU" term="%22Chalopin+T%22">Chalopin T</searchLink>; Hematology, CHU, Tours, France.<br /><searchLink fieldCode="AU" term="%22Slama+B%22">Slama B</searchLink>; Hospital center, Avignon, France.<br /><searchLink fieldCode="AU" term="%22Chretien+ML%22">Chretien ML</searchLink>; Hematology, University Hospital, Inserm U1231, University of Burgundy Franche-Comté, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Laribi+K%22">Laribi K</searchLink>; Hematology, CH, Le Mans, France.<br /><searchLink fieldCode="AU" term="%22Dingremont+C%22">Dingremont C</searchLink>; Internal Medicine, Tarbes-Lourdes Hospital, Tarbes, France.<br /><searchLink fieldCode="AU" term="%22Roul+C%22">Roul C</searchLink>; CH La Rochelle, La Rochelle, France.<br /><searchLink fieldCode="AU" term="%22Mariette+C%22">Mariette C</searchLink>; Hematology, CHU, Grenoble, France.<br /><searchLink fieldCode="AU" term="%22Rigaudeau+S%22">Rigaudeau S</searchLink>; Hématologie - Le Chesnay, CH Versaille, Paris, France.<br /><searchLink fieldCode="AU" term="%22Calmettes+C%22">Calmettes C</searchLink>; CH, Périgueux, France.<br /><searchLink fieldCode="AU" term="%22Dib+M%22">Dib M</searchLink>; University Hospital, Angers, France.<br /><searchLink fieldCode="AU" term="%22Tiab+M%22">Tiab M</searchLink>; Hematology, CH Departemental de La Roche-sur-Yon, La Roche-sur-Yon, France.<br /><searchLink fieldCode="AU" term="%22Vincent+L%22">Vincent L</searchLink>; CHU, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Delaunay+J%22">Delaunay J</searchLink>; Hôpital privé du confluent 2, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Santagostino+A%22">Santagostino A</searchLink>; Hematology, CH, Troyes, France.<br /><searchLink fieldCode="AU" term="%22Macro+M%22">Macro M</searchLink>; Hematology, IHBN - CHU, Caen, France.<br /><searchLink fieldCode="AU" term="%22Bourgeois+E%22">Bourgeois E</searchLink>; GHICL, Lille, France.<br /><searchLink fieldCode="AU" term="%22Orsini-Piocelle+F%22">Orsini-Piocelle F</searchLink>; Hématologie, CH, Annecy Genevois, France.<br /><searchLink fieldCode="AU" term="%22Gay+J%22">Gay J</searchLink>; Hematology, CH de la côte basque, Bayonne, France.<br /><searchLink fieldCode="AU" term="%22Bareau+B%22">Bareau B</searchLink>; Hematology, Les Hôpitaux Privés Rennais Cesson Sévigné - Vivalto Santé, Cesson Sévigné, France.<br /><searchLink fieldCode="AU" term="%22Bigot+N%22">Bigot N</searchLink>; SBIM, Saint-Louis Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Vergez+F%22">Vergez F</searchLink>; Unit for Genomics in Myeloma, iUCT Oncopole, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Lebreton+P%22">Lebreton P</searchLink>; Hematology, CH, Le Havre, France.<br /><searchLink fieldCode="AU" term="%22Tabrizi+R%22">Tabrizi R</searchLink>; Hematology, CHI de Mont De Marsan, Mont-de-Marsan, France.<br /><searchLink fieldCode="AU" term="%22Waultier-Rascalou+A%22">Waultier-Rascalou A</searchLink>; Hematology, CHU, Nîmes, France.<br /><searchLink fieldCode="AU" term="%22Frenzel+L%22">Frenzel L</searchLink>; Hematology, Necker Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Le+Calloch+R%22">Le Calloch R</searchLink>; Hematology, CH de Cornouaille, Quimper Concarneau, Concarneau, France.<br /><searchLink fieldCode="AU" term="%22Chalayer+E%22">Chalayer E</searchLink>; Hematology, CHU, Saint-Etienne, France.<br /><searchLink fieldCode="AU" term="%22Braun+T%22">Braun T</searchLink>; Hematology, Avicenne hospital APHP, Bobigny, France.<br /><searchLink fieldCode="AU" term="%22Lachenal+F%22">Lachenal F</searchLink>; CH Pierre Oudot, Bourgoin-Jallieu, France.<br /><searchLink fieldCode="AU" term="%22Corm+S%22">Corm S</searchLink>; Medipole de Savoie, Challes les Eaux, France.<br /><searchLink fieldCode="AU" term="%22Kennel+C%22">Kennel C</searchLink>; CH William Morey, Chalon sur Saône, France.<br /><searchLink fieldCode="AU" term="%22Belkhir+R%22">Belkhir R</searchLink>; Rheumatology, Hopital Bicetre, AP-HP, Universite Paris Saclay, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bladé+JS%22">Bladé JS</searchLink>; Onco-Hematology Department, HIA Sainte Anne, Toulon, France.<br /><searchLink fieldCode="AU" term="%22Joly+B%22">Joly B</searchLink>; CH Sud Francilien, Corbeil Essonnes, France.<br /><searchLink fieldCode="AU" term="%22Richez-Olivier+V%22">Richez-Olivier V</searchLink>; CHU de Nice, Nice, France.<br /><searchLink fieldCode="AU" term="%22Gardeney+H%22">Gardeney H</searchLink>; Hematology, CIC 1082, U1313, CHU, University, Poitiers, France.<br /><searchLink fieldCode="AU" term="%22Demarquette+H%22">Demarquette H</searchLink>; Hematology, CH, Dunkerque, France.<br /><searchLink fieldCode="AU" term="%22Robu-Cretu+D%22">Robu-Cretu D</searchLink>; Hematology, CH, Lens, France.<br /><searchLink fieldCode="AU" term="%22Garderet+L%22">Garderet L</searchLink>; Hopital Pitié Salpetriere, hématologie APHP, Paris, France.<br /><searchLink fieldCode="AU" term="%22Newinger-Porte+M%22">Newinger-Porte M</searchLink>; Hôpital Emile Muller, Mulhouse, France.<br /><searchLink fieldCode="AU" term="%22Kasmi+A%22">Kasmi A</searchLink>; DRC, CHU, Poitiers, France.<br /><searchLink fieldCode="AU" term="%22Royer+B%22">Royer B</searchLink>; Hôpital Saint-Louis, Paris, France.<br /><searchLink fieldCode="AU" term="%22Decaux+O%22">Decaux O</searchLink>; Hematology, UMR U1236, University Hospital, Rennes, France.<br /><searchLink fieldCode="AU" term="%22Arnulf+B%22">Arnulf B</searchLink>; Hôpital Saint-Louis, Paris, France.<br /><searchLink fieldCode="AU" term="%22Belhadj+K%22">Belhadj K</searchLink>; C.H.U. Henri Mondor, Créteil, France.<br /><searchLink fieldCode="AU" term="%22Touzeau+C%22">Touzeau C</searchLink>; Hématologie, CHU Hotel Dieu Université, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Mohty+M%22">Mohty M</searchLink>; Hematology, Sorbonne University, Saint-Antoine Hôpital (AP-HP), UMRs 938, Paris, France.<br /><searchLink fieldCode="AU" term="%22Manier+S%22">Manier S</searchLink>; Hematology, University Hospital Inserm U-S1277 and CNRS UMR9020, Lille, France.<br /><searchLink fieldCode="AU" term="%22Moreau+P%22">Moreau P</searchLink>; Hématologie, CHU Hotel Dieu Université, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Avet-Loiseau+H%22">Avet-Loiseau H</searchLink>; Unit for Genomics in Myeloma, iUCT Oncopole, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Corre+J%22">Corre J</searchLink>; Unit for Genomics in Myeloma, iUCT Oncopole, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Facon+T%22">Facon T</searchLink>; Hematology, University Hospital Inserm U-S1277 and CNRS UMR9020, Lille, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2024 Aug; Vol. 30 (8), pp. 2235-2241. <i>Date of Electronic Publication: </i>2024 Jun 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38830994
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41591-024-03050-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2235
    Titles:
      – TitleFull: Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Leleu X
      – PersonEntity:
          Name:
            NameFull: Hulin C
      – PersonEntity:
          Name:
            NameFull: Lambert J
      – PersonEntity:
          Name:
            NameFull: Bobin A
      – PersonEntity:
          Name:
            NameFull: Perrot A
      – PersonEntity:
          Name:
            NameFull: Karlin L
      – PersonEntity:
          Name:
            NameFull: Roussel M
      – PersonEntity:
          Name:
            NameFull: Montes L
      – PersonEntity:
          Name:
            NameFull: Cherel B
      – PersonEntity:
          Name:
            NameFull: Chalopin T
      – PersonEntity:
          Name:
            NameFull: Slama B
      – PersonEntity:
          Name:
            NameFull: Chretien ML
      – PersonEntity:
          Name:
            NameFull: Laribi K
      – PersonEntity:
          Name:
            NameFull: Dingremont C
      – PersonEntity:
          Name:
            NameFull: Roul C
      – PersonEntity:
          Name:
            NameFull: Mariette C
      – PersonEntity:
          Name:
            NameFull: Rigaudeau S
      – PersonEntity:
          Name:
            NameFull: Calmettes C
      – PersonEntity:
          Name:
            NameFull: Dib M
      – PersonEntity:
          Name:
            NameFull: Tiab M
      – PersonEntity:
          Name:
            NameFull: Vincent L
      – PersonEntity:
          Name:
            NameFull: Delaunay J
      – PersonEntity:
          Name:
            NameFull: Santagostino A
      – PersonEntity:
          Name:
            NameFull: Macro M
      – PersonEntity:
          Name:
            NameFull: Bourgeois E
      – PersonEntity:
          Name:
            NameFull: Orsini-Piocelle F
      – PersonEntity:
          Name:
            NameFull: Gay J
      – PersonEntity:
          Name:
            NameFull: Bareau B
      – PersonEntity:
          Name:
            NameFull: Bigot N
      – PersonEntity:
          Name:
            NameFull: Vergez F
      – PersonEntity:
          Name:
            NameFull: Lebreton P
      – PersonEntity:
          Name:
            NameFull: Tabrizi R
      – PersonEntity:
          Name:
            NameFull: Waultier-Rascalou A
      – PersonEntity:
          Name:
            NameFull: Frenzel L
      – PersonEntity:
          Name:
            NameFull: Le Calloch R
      – PersonEntity:
          Name:
            NameFull: Chalayer E
      – PersonEntity:
          Name:
            NameFull: Braun T
      – PersonEntity:
          Name:
            NameFull: Lachenal F
      – PersonEntity:
          Name:
            NameFull: Corm S
      – PersonEntity:
          Name:
            NameFull: Kennel C
      – PersonEntity:
          Name:
            NameFull: Belkhir R
      – PersonEntity:
          Name:
            NameFull: Bladé JS
      – PersonEntity:
          Name:
            NameFull: Joly B
      – PersonEntity:
          Name:
            NameFull: Richez-Olivier V
      – PersonEntity:
          Name:
            NameFull: Gardeney H
      – PersonEntity:
          Name:
            NameFull: Demarquette H
      – PersonEntity:
          Name:
            NameFull: Robu-Cretu D
      – PersonEntity:
          Name:
            NameFull: Garderet L
      – PersonEntity:
          Name:
            NameFull: Newinger-Porte M
      – PersonEntity:
          Name:
            NameFull: Kasmi A
      – PersonEntity:
          Name:
            NameFull: Royer B
      – PersonEntity:
          Name:
            NameFull: Decaux O
      – PersonEntity:
          Name:
            NameFull: Arnulf B
      – PersonEntity:
          Name:
            NameFull: Belhadj K
      – PersonEntity:
          Name:
            NameFull: Touzeau C
      – PersonEntity:
          Name:
            NameFull: Mohty M
      – PersonEntity:
          Name:
            NameFull: Manier S
      – PersonEntity:
          Name:
            NameFull: Moreau P
      – PersonEntity:
          Name:
            NameFull: Avet-Loiseau H
      – PersonEntity:
          Name:
            NameFull: Corre J
      – PersonEntity:
          Name:
            NameFull: Facon T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2024 Aug
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1546-170X
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Nature medicine
              Type: main
ResultId 1